<unk>  is a antibiotic that is FDA approved for the treatment of community-acquired pneumonia (of mild to moderate severity) due to Streptococcus pneumoniae, (including multi-drug resistant isolates [MDRSP3]), Haemophilus influenzae, Moraxella catarrhalis, Chlamydophila pneumoniae, or Mycoplasma pneumoniae, for patients 18 years old and above. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include diarrhea, nausea, vomiting,  dizziness, headache,  abnormal vision , blurred vision, diplopia, problem of visual accommodation.
Telithromycin
Azithromycin 
Dirithromycin
Roxithromycin
Tedizolid
Moxifloxacin 
Nadifloxacin
Balofloxacin